Showing results (11-20 of 83) with videos related to
Sort By:
Pageof 9
Cancer Treatment and Research Communications|February 21, 2021
Pemigatinib: Hot topics behind the first approval of a targeted therapy in cholangiocarcinomaAlessandro Rizzo, Angela Dalia Ricci, Giovanni BrandiJournal of Personalized Medicine|December 29, 2022
Trans-Arterial Chemoembolization Plus Systemic Treatments for Hepatocellular Carcinoma: An UpdateAlessandro Rizzo, Angela Dalia Ricci, Giovanni BrandiExpert Opinion on Investigational Drugs|October 15, 2020
Futibatinib, an investigational agent for the treatment of intrahepatic cholangiocarcinoma: evidence to date and future perspectivesAlessandro Rizzo, Angela Dalia Ricci, Giovanni BrandiImmunotherapy|April 6, 2021
Atezolizumab in advanced hepatocellular carcinoma: good things come to those who waitAlessandro Rizzo, Angela Dalia Ricci, Giovanni BrandiCancer Genomics & Proteomics|August 30, 2020
Circulating Tumor DNA in Biliary Tract Cancer: Current Evidence and Future PerspectivesAlessandro Rizzo, Angela Dalia Ricci, Simona Tavolari, et al.Expert Review of Gastroenterology & Hepatology|August 25, 2021
First-line immune checkpoint inhibitor-based combinations in unresectable hepatocellular carcinoma: current management and future challengesAlessandro Rizzo, Angela Dalia Ricci, Gennaro Gadaleta-Caldarola, et al.Journal of the National Comprehensive Cancer Network : JNCCN|April 7, 2023
Anaplastic Classic Kaposi Sarcoma: PD-L1 Expression and Response to Immunotherapy: A Case Report and Review of the LiteratureIvan Lolli, Anna Maria Valentini, Angela Dalia Ricci, et al.Current Oncology (Toronto, Ont.)|September 30, 2021
Ampullary Carcinoma: An Overview of a Rare Entity and Discussion of Current and Future Therapeutic ChallengesAlessandro Rizzo, Vincenzo Dadduzio, Lucia Lombardi, et al.Expert Review of Gastroenterology & Hepatology|March 31, 2021
FGFR inhibitors in elderly patients with advanced biliary tract cancer: an unsolved issueAlessandro Rizzo, Angela Dalia Ricci, Giorgio Frega, et al.Cancers|April 3, 2020
Landscape and Future Perspectives of Immunotherapy in Neuroendocrine NeoplasiaIlaria Maggio, Lisa Manuzzi, Giuseppe Lamberti, et al.Pageof 9